Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Path Holdings (BPTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bio-Path Holdings 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 USA

P: 832-742-1357

Description:

BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.

Key Statistics

Overview:

Market Capitalization, $K 12,758
Shares Outstanding, K 11,340
Annual Sales, $ 40 K
Annual Net Income, $ -7,020 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,920 K
36-Month Beta 3.07
% of Insider Shareholders 11.20%
% of Institutional Shareholders 8.96%

Growth:

1-Year Total Return -71.58%
3-Year Total Return -89.08%
5-Year Total Return -88.28%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/08/18
Earnings Per Share ttm -0.67
EPS Growth vs. Prev Qtr 11.76%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 02/09/18

BPTH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.26
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -128.86
Return-on-Assets (Before Tax) -113.36
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 343.30
Price/Cash Flow N/A
Price/Book 2.69
Book Value/Share -0.55
Interest Coverage N/A
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar